Generic drug manufacturers will have to place their drugs on stability longer and test more batches under new requirements scheduled to take effect Jan. 1, 2014.
These new requirements will take effect for all abbreviated new drug applications and the drug master files that support them,...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?